A multicenter phase II trial of pre-operative chemotherapy with Gemcitabine/ Cisplatin /S-1 for biliary tract cancers with lymph node metastasis diagnosed by FDG-PET
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 31 Aug 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2017.
- 28 Mar 2013 Planned end date changed to 1 Feb 2019 as reported by ClinicalTrials.gov record.
- 28 Mar 2013 New source identified and integrated (ClinicalTrials.gov; NCT01821248).